Clinical trials
Recruiting Breast Neoplasms trials in Colombia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo | 3 |
| Merck Sharp & Dohme LLC | 3 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| Establishment Labs | 1 |
| Fundación Santa Fe de Bogota | 1 |
| Hoffmann-La Roche | 1 |
| NRG Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 12 |
| Colorectal Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Head and Neck Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| COVID-19 | 1 |
| Neoplasm Recurrence, Local | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.